Table 2.
IL-2 |
Control |
|||||||
---|---|---|---|---|---|---|---|---|
CD4 | Pt yrs | Events | Ratea) | Pt yrs | Events | Ratea) | HRb) | p-val |
< 100 | 64 | 2 | 3.13 | 60 | 1 | 1.66 | 1.93 | .59 |
100 - 199 | 194 | 2 | 1.03 | 212 | 3 | 1.41 | 0.77 | .77 |
200 - 349 | 1117 | 12 | 1.07 | 1879 | 21 | 1.12 | 1.01 | .97 |
350 - 499 | 2540 | 23 | 0.91 | 4011 | 24 | 0.60 | 1.55 | .13 |
500 - 699 | 3639 | 22 | 0.60 | 4253 | 23 | 0.54 | 1.11 | .73 |
≥ 700 | 6281 | 32 | 0.51 | 3131 | 14 | 0.45 | 1.10 | .77 |
Total | 13836 | 93 | 0.67 | 13547 | 86 | 0.63 | ||
| ||||||||
HR (p) for 100 cells c) | 0.89 (.001) | 0.90 (.05) | Int.d) | |||||
CD4 Coeff (SE) | −0.0012 (0.0004) | −0.0010 (0.0005) | .71 | |||||
Log10 CD4 Coeff (SE) | −1.537 (0.375) | −1.194 (0.461) | .62 |
Rate per 100 person yrs of follow-up in that category. Events are attributed to last CD4 recorded prior to the event. Assumes patient stays in that category until a CD4 is measured in an alternate category, or until the censoring date. Uses interim and visit-associated lab values.
Hazard ratio (IL-2 vs. control) and p-value from Cox model with treatment group and time-updated CD4 strata.
HR and p-value for time-updated CD4 (100 cells) from Cox model, run separately by treatment group.
Interaction p-value is for treatment group by time-updated CD4 in a model containing time-updated CD4, treatment group, and an interaction term.